PO-0966: Prognostic value of tissue necrosis, CD34 MVD and CA-IX in head and neck cancer patients. (May 2017) - Ou, D.; Garberis, I.; Adam, J.; Blanchard, P.; Nguyen, F.; Levy, A.; Casiraghi, O.; Gorphe, P.; Breuskin, I.; Janot, F.; Temam, S.; Scoazec, J.; et al.